BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10354127)

  • 1. Platelet glycoprotein IIIa polymorphism HPA 1b (PlA2): no association with platelet fibrinogen binding.
    Meiklejohn DJ; Urbaniak SJ; Greaves M
    Br J Haematol; 1999 Jun; 105(3):664-6. PubMed ID: 10354127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased binding of fibrinogen to glycoprotein IIIa-proline33 (HPA-1b, PlA2, Zwb) positive platelets in patients with cardiovascular disease.
    Goodall AH; Curzen N; Panesar M; Hurd C; Knight CJ; Ouwehand WH; Fox KM
    Eur Heart J; 1999 May; 20(10):742-7. PubMed ID: 10329065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo platelet activation in atherothrombotic stroke is not determined by polymorphisms of human platelet glycoprotein IIIa or Ib.
    Meiklejohn DJ; Vickers MA; Morrison ER; Dijkhuisen R; Moore I; Urbaniak SJ; Greaves M
    Br J Haematol; 2001 Mar; 112(3):621-31. PubMed ID: 11260063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists.
    Michelson AD; Furman MI; Goldschmidt-Clermont P; Mascelli MA; Hendrix C; Coleman L; Hamlington J; Barnard MR; Kickler T; Christie DJ; Kundu S; Bray PF
    Circulation; 2000 Mar; 101(9):1013-8. PubMed ID: 10704169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of the human platelet antigens HPA-1, HPA-2, HPA-3, and HPA-5 on the platelet receptors for fibrinogen (GPIIb/IIIa), von Willebrand factor (GPIb/IX), and collagen (GPIa/IIa) are not correlated with an increased risk for stroke.
    Carlsson LE; Greinacher A; Spitzer C; Walther R; Kessler C
    Stroke; 1997 Jul; 28(7):1392-5. PubMed ID: 9227689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Variations in glycoprotein IIb-IIIa (alphaIIb/beta3-integrin) content in healthy donors. Influence on platelet aggregation activity and efficacy of aspirin action].
    Khaspekova SG; Sirotkina OV; Shimanova IuV; Mazurov AV
    Biomed Khim; 2008; 54(3):361-71. PubMed ID: 18712091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycoprotein IIb-IIIa content and platelet aggregation in healthy volunteers and patients with acute coronary syndrome.
    Yakushkin VV; Zyuryaev IT; Khaspekova SG; Sirotkina OV; Ruda MY; Mazurov AV
    Platelets; 2011; 22(4):243-51. PubMed ID: 21329420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective platelet response to arachidonic acid and thromboxane A(2) in subjects with Pl(A2) polymorphism of beta(3) subunit (glycoprotein IIIa).
    Andrioli G; Minuz P; Solero P; Pincelli S; Ortolani R; Lussignoli S; Bellavite P
    Br J Haematol; 2000 Sep; 110(4):911-8. PubMed ID: 11054082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human platelet alloantigen polymorphism in Glanzmann's thrombasthenia and its impact on the severity of the disease.
    Ghosh K; Kulkarni B; Nair S; Shetty S; Mohanty D
    Br J Haematol; 2002 Nov; 119(2):348-53. PubMed ID: 12406067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet glycoprotein IIIa Pl(a) polymorphism, fibrinogen, and platelet aggregability: The Framingham Heart Study.
    Feng D; Lindpaintner K; Larson MG; O'Donnell CJ; Lipinska I; Sutherland PA; Mittleman M; Muller JE; D'Agostino RB; Levy D; Tofler GH
    Circulation; 2001 Jul; 104(2):140-4. PubMed ID: 11447076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double heterozygosity polymorphisms for platelet glycoproteins Ia/IIa and IIb/IIIa increases arterial thrombosis and arteriosclerosis in patients with the antiphospholipid syndrome or with systemic lupus erythematosus.
    Jiménez S; Tàssies D; Espinosa G; García-Criado A; Plaza J; Monteagudo J; Cervera R; Reverter JC
    Ann Rheum Dis; 2008 Jun; 67(6):835-40. PubMed ID: 17728329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the Pl(A2) alloantigen on the function of beta(3)-integrins in platelets.
    Bennett JS; Catella-Lawson F; Rut AR; Vilaire G; Qi W; Kapoor SC; Murphy S; FitzGerald GA
    Blood; 2001 May; 97(10):3093-9. PubMed ID: 11342435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism of platelet membrane glycoprotein IIIa: human platelet antigen 1b (HPA-1b/PlA2) is an inherited risk factor for premature myocardial infarction in coronary artery disease.
    Zotz RB; Winkelmann BR; Nauck M; Giers G; Maruhn-Debowski B; März W; Scharf RE
    Thromb Haemost; 1998 Apr; 79(4):731-5. PubMed ID: 9569182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet glycoprotein IIb/IIIa genetic polymorphism is associated with plasma fibrinogen levels in myocardial infarction patients. The REGICOR Investigators.
    Sentí M; Aubó C; Bosch M; Pavesi M; Pena A; Masiá R; Marrugat J
    Clin Biochem; 1998 Nov; 31(8):647-51. PubMed ID: 9876897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the platelet glycoprotein IIb HPA-3 polymorphism with survival after acute ischemic stroke.
    Carter AM; Catto AJ; Bamford JM; Grant PJ
    Stroke; 1999 Dec; 30(12):2606-11. PubMed ID: 10582985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradoxical inhibition of fibrinogen binding and potentiation of alpha-granule release by specific types of inhibitors of glycoprotein IIb-IIIa.
    Schneider DJ; Taatjes DJ; Sobel BE
    Cardiovasc Res; 2000 Jan; 45(2):437-46. PubMed ID: 10728364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking and the platelet fibrinogen receptor glycoprotein IIb/IIIA PlA1/A2 polymorphism interact in the risk of lacunar stroke and midterm survival.
    Oksala NK; Heikkinen M; Mikkelsson J; Pohjasvaara T; Kaste M; Erkinjuntti T; Karhunen PJ
    Stroke; 2007 Jan; 38(1):50-5. PubMed ID: 17138951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociation of glycoprotein IIb/IIIa antagonists from platelets does not result in fibrinogen binding or platelet aggregation.
    Frelinger AL; Furman MI; Krueger LA; Barnard MR; Michelson AD
    Circulation; 2001 Sep; 104(12):1374-9. PubMed ID: 11560852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of an antibody-based genotype classification of the platelet fibrinogen receptor (GPIIb/IIIa).
    Schwippert-Houtermans B; Strapatsakis S; Roesen P; Tschoepe D
    Cytometry; 2001 Aug; 46(4):238-42. PubMed ID: 11514957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of inhibitory effects of glycoprotein IIb-IIIa antagonists in patients with diabetes.
    Keating FK; Whitaker DA; Sobel BE; Schneider DJ
    Thromb Res; 2004; 113(1):27-34. PubMed ID: 15081562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.